Hwaseong, South Korea

Su-Young Lee

This inventor holds 1 USPTO granted patent. Top assignee: Yuhan Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Su-Young Lee. Retrieved from https://idiyas.com/inventor/su-young-lee-wykevm9p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Su-Young Lee: Innovator in Pharmaceutical Processes

Introduction

Su-Young Lee is a prominent inventor based in Hwaseong-si, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the preparation of key chemical compounds. Her work is essential for the development of important medications.

Latest Patents

Su-Young Lee holds a patent for "Processes for preparing (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine or a salt thereof and processes for preparing tofacitinib using the same." This patent outlines a process for preparing an intermediate compound that is crucial for the synthesis of tofacitinib, a medication used to treat various autoimmune diseases. The patent emphasizes the stability of the intermediate compounds, which enhances the efficiency of the drug preparation process.

Career Highlights

Su-Young Lee is currently employed at Yuhan Corporation, a leading pharmaceutical company in South Korea. Her innovative work has positioned her as a key player in the development of new therapeutic agents. She has demonstrated a strong commitment to advancing pharmaceutical science through her research and inventions.

Collaborations

Su-Young Lee has collaborated with notable colleagues, including Sang-Ho Oh and Doo-Byung Lee. These partnerships have fostered a collaborative environment that enhances the research and development efforts at Yuhan Corporation.

Conclusion

Su-Young Lee's contributions to pharmaceutical processes exemplify her dedication to innovation in the field. Her patent for the preparation of tofacitinib intermediates showcases her expertise and commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…